American Century Companies’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$904K Buy
110,066
+8,487
+8% +$69.7K ﹤0.01% 2330
2025
Q1
$726K Buy
101,579
+6,553
+7% +$46.9K ﹤0.01% 2368
2024
Q4
$735K Buy
95,026
+7,658
+9% +$59.2K ﹤0.01% 2362
2024
Q3
$916K Buy
87,368
+12,496
+17% +$131K ﹤0.01% 2273
2024
Q2
$876K Buy
74,872
+10,767
+17% +$126K ﹤0.01% 2221
2024
Q1
$1.35M Buy
64,105
+15,059
+31% +$317K ﹤0.01% 2031
2023
Q4
$880K Sell
49,046
-168,652
-77% -$3.03M ﹤0.01% 2124
2023
Q3
$3.58M Sell
217,698
-47,749
-18% -$786K ﹤0.01% 1465
2023
Q2
$5.31M Sell
265,447
-115,304
-30% -$2.3M ﹤0.01% 1286
2023
Q1
$7.2M Sell
380,751
-3,181
-0.8% -$60.2K 0.01% 1120
2022
Q4
$8.71M Buy
383,932
+69,214
+22% +$1.57M 0.01% 1023
2022
Q3
$8.32M Buy
314,718
+75,053
+31% +$1.98M 0.01% 948
2022
Q2
$5.92M Buy
239,665
+191,668
+399% +$4.73M ﹤0.01% 1072
2022
Q1
$1.59M Buy
+47,997
New +$1.59M ﹤0.01% 1492
2020
Q1
Sell
-104,713
Closed -$4.29M 1697
2019
Q4
$4.29M Buy
104,713
+42,438
+68% +$1.74M ﹤0.01% 827
2019
Q3
$2.22M Buy
62,275
+3,626
+6% +$129K ﹤0.01% 955
2019
Q2
$3.01M Sell
58,649
-31,491
-35% -$1.62M ﹤0.01% 947
2019
Q1
$5.17M Buy
90,140
+41,483
+85% +$2.38M 0.01% 801
2018
Q4
$2.04M Buy
48,657
+32,734
+206% +$1.37M ﹤0.01% 969
2018
Q3
$1.2M Buy
15,923
+419
+3% +$31.6K ﹤0.01% 1082
2018
Q2
$1.11M Buy
+15,504
New +$1.11M ﹤0.01% 1093